GILD

Gilead Sciences

$143.77

-3.35 (-2.28%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 27.02.2026
$156.59
(+8.92%)
Strong Buy: 5
Buy: 17
Hold: 6
Sell: 0
Strong Sell: 1
Description:
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
333 LAKESIDE DRIVE, FOSTER CITY, CA, UNITED STATES, 94404
Fiscal year end:
December
Market capitalization:
$183 Billion
EBITDA:
$14.6 Billion
PERatio:
21.7
EPS:
6.78
Dividend per share:
$3.16
Dividend yield:
2.14%
Beta:
0.387

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+143%
How much will you get:
$2,433
Prices dates:
29-01-2016: $58.34 and 30-01-2026: $141.95